We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Novel Digital Morphology Analyzer Performance Evaluated

By LabMedica International staff writers
Posted on 01 Dec 2022

Microscopic examination of peripheral blood smear (PBS) is essential in clinical hematology laboratories. More...

Manual counting is, however, inefficient because the process is technically demanding and labor-intensive resulting in long turnaround time (TAT), and the results may be subjective with inter-observer variation.

Digital morphology (DM) analyzers can provide analysis of cell morphology (pre-classification) with reduced TAT and inter-observer variation. In a recent study, DM analyzers showed advantages over manual counting in laboratory efficiency including shortened TAT. DM analyzers can be used mainly in large-volume laboratories, and they are too large and expensive to be used in small to medium-volume laboratories.

Medical Laboratory Scientists at the Konkuk University School of Medicine (Seoul, Korea) obtained PBS slides from healthy individuals, spanning normal white blood cell (WBC) range including mild leukopenia (2.0–4.0 × 109/L) and mild leukocytosis (10.0–15.0 × 109/L). WBC counts in these samples were 3.90 × 109/L, 5.19 × 109/L, 6.72 × 109/L, 8.72 × 109/L, and 10.78 × 109/L, respectively. Venous whole blood samples were collected and were used for complete blood counts in XN-9000 (Sysmex, Kobe, Japan), and PBS slides were made and reviewed for WBC differentials.

The Sysmex CellaVision DC-1 (DC1) is a newly launched digital morphology analyzer that was developed mainly for small to medium-volume laboratories. The scientists evaluated the precision, qualitative performance, comparison of cell counts between DC-1 and manual counting, and turnaround time (TAT) of DC-1. Pre-classification on DC-1 included total 18 cell classes (12 WBC classes and six non-WBC classes). The 12 WBC classes include blasts, promyelocytes, myelocytes, metamyelocytes, band neutrophils, segmented neutrophils, lymphocytes, monocytes, eosinophils, basophils, variant lymphocytes, and plasma cells. The six non-WBC classes include nucleated RBCs (nRBCs), smudge cells, artifact, giant platelet, platelet aggregation, and unidentified cells.

The investigators reported that DC-1 showed excellent precision (%CV, 0.0%–3.5%), high specificity (98.9%–100.0%), and high negative predictive value (98.4%–100.0%) in 18 cell classes (12 WBC classes and six non-WBC classes). However, DC-1 showed 0% of positive predictive value in seven cell classes (metamyelocytes, myelocytes, promyelocytes, blasts, plasma cells, nucleated red blood cells, and unidentified). The largest absolute mean differences (%) of DC-1 versus manual counting was 2.74. Total TAT (min:s) was comparable between DC-1 (8:55) and manual counting (8:55).

The authors concluded that their study showed that DC-1 has a reliable analytical performance in all cell classes, and it can be used in small-to medium-volume laboratories for providing assist of manpower in daily practice of PBS review. However, DC-1 may make unnecessary workload for cell verification in some cell classes. The study was published on October 31, 2022 in the journal Clinical Chemistry and Laboratory Medicine.

Related Links:
Konkuk University School of Medicine
Sysmex


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.